By Hugo Francisco de Souza Reviewed by Lauren Hardaker Jun 17 2025 Real-world data analysis reveals GLP-1 drugs can protect kidneys and hearts in diabetic patients but also introduce surprising new health risks. Study:  Real-world comparative outcomes of GLP-1 RA and semaglutide prescription among individuals with type 2 diabetes . Image credit: MillaF/Shutterstock.com *Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be